264 related articles for article (PubMed ID: 17914106)
1. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal instability predicts metastatic disease in patients with insulinomas.
Jonkers YM; Claessen SM; Perren A; Schmid S; Komminoth P; Verhofstad AA; Hofland LJ; de Krijger RR; Slootweg PJ; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2005 Jun; 12(2):435-47. PubMed ID: 15947114
[TBL] [Abstract][Full Text] [Related]
3. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.
Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P
Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358
[TBL] [Abstract][Full Text] [Related]
4. Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.
Jonkers YM; Claessen SM; Veltman JA; Geurts van Kessel A; Dinjens WN; Skogseid B; Ramaekers FC; Speel EJ
Cytogenet Genome Res; 2006; 115(3-4):289-97. PubMed ID: 17124412
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
[TBL] [Abstract][Full Text] [Related]
6. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.
Speel EJ; Richter J; Moch H; Egenter C; Saremaslani P; Rütimann K; Zhao J; Barghorn A; Roth J; Heitz PU; Komminoth P
Am J Pathol; 1999 Dec; 155(6):1787-94. PubMed ID: 10595906
[TBL] [Abstract][Full Text] [Related]
7. [Pancreatic endocrine tumors].
Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
Roldo C; Missiaglia E; Hagan JP; Falconi M; Capelli P; Bersani S; Calin GA; Volinia S; Liu CG; Scarpa A; Croce CM
J Clin Oncol; 2006 Oct; 24(29):4677-84. PubMed ID: 16966691
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
[TBL] [Abstract][Full Text] [Related]
10. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A
Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224
[TBL] [Abstract][Full Text] [Related]
11. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
13. The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value.
Iino S; Abeyama K; Kawahara K; Yamakuchi M; Hashiguchi T; Matsukita S; Yonezawa S; Taniguchi S; Nakata M; Takao S; Aikou T; Maruyama I
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6179-88. PubMed ID: 15448005
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors.
Akao J; Matsuyama H; Yamamoto Y; Sasaki K; Naito K
Clin Cancer Res; 2006 Dec; 12(23):7004-8. PubMed ID: 17145821
[TBL] [Abstract][Full Text] [Related]
15. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ
J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
17. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.
Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR
Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983
[TBL] [Abstract][Full Text] [Related]
18. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
20. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]